EBS logo

EBS
Emergent Biosolutions Inc

7,461
Mkt Cap
$629.6M
Volume
568,158.00
52W High
$13.41
52W Low
$4.02
PE Ratio
8.82
EBS Fundamentals
Price
$11.41
Prev Close
$11.72
Open
$11.77
50D MA
$10.38
Beta
2.18
Avg. Volume
1.03M
EPS (Annual)
-$3.60
P/B
1.03
Rev/Employee
$1.16M
Loading...
Loading...
News
all
press releases
Ronald Richard Sells 21,984 Shares of Emergent Biosolutions (NYSE:EBS) Stock
Emergent Biosolutions Inc. (NYSE:EBS - Get Free Report) Director Ronald Richard sold 21,984 shares of the business's stock in a transaction dated Friday, December 5th. The stock was sold at an...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Emergent Biosolutions (NYSE:EBS) Director Sells $263,148.48 in Stock
Emergent Biosolutions Inc. (NYSE:EBS - Get Free Report) Director Ronald Richard sold 21,984 shares of the company's stock in a transaction on Friday, December 5th. The stock was sold at an average...
MarketBeat·3d ago
News Placeholder
Emergent Biosolutions Inc. $EBS Stock Holdings Increased by Geode Capital Management LLC
Geode Capital Management LLC grew its position in shares of Emergent Biosolutions Inc. (NYSE:EBS - Free Report) by 108.9% during the second quarter, according to the company in its most recent 13F...
MarketBeat·8d ago
News Placeholder
Qiagen (QGEN) Up 6.3% Since Last Earnings Report: Can It Continue?
Qiagen (QGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·9d ago
News Placeholder
Emergent Biosolutions (NYSE:EBS) Trading 10.4% Higher - Here's Why
Emergent Biosolutions (NYSE:EBS) Stock Price Up 10.4% - What's Next...
MarketBeat·21d ago
News Placeholder
Emergent Biosolutions (NYSE:EBS) Downgraded to "Buy" Rating by Wall Street Zen
Wall Street Zen downgraded Emergent Biosolutions from a "strong-buy" rating to a "buy" rating in a research note on Saturday...
MarketBeat·21d ago
News Placeholder
Emergent Biosolutions Inc. $EBS Position Increased by Connor Clark & Lunn Investment Management Ltd.
Connor Clark & Lunn Investment Management Ltd. boosted its holdings in Emergent Biosolutions Inc. (NYSE:EBS - Free Report) by 5.9% during the 2nd quarter, according to the company in its most recent...
MarketBeat·29d ago
News Placeholder
Acadian Asset Management LLC Increases Position in Emergent Biosolutions Inc. $EBS
Acadian Asset Management LLC boosted its stake in shares of Emergent Biosolutions Inc. (NYSE:EBS - Free Report) by 17.0% during the second quarter, according to the company in its most recent Form...
MarketBeat·30d ago
News Placeholder
Black Diamond Therapeutics, Inc. (BDTX) Hits Fresh High: Is There Still Room to Run?
Black Diamond (BDTX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks·1mo ago
News Placeholder
Director Of Emergent BioSolutions Makes $85K Sale
read more...
Benzinga·1mo ago

Latest EBS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.